FDA Inspection 1272273 — Janssen Biologics B.V.
The FDA completed an inspection of Janssen Biologics B.V. on Jun 1, 2023 in Leiden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 1, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Leiden (Netherlands)
Additional details
Mutual Recognition Agreement (MRA)